Stephen Schuster, MD, discusses findings from follow-up of the phase 2 ELARA study presented at the 2023 ASH Annual Meeting.
Stephen J. Schuster, MD
Stephen J. Schuster, MD is the director of the lymphoma program, director of lymphoma rranslational research, and the Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research at Penn Medicine.
Articles by Stephen J. Schuster, MD
Stephen J. Schuster, MD, discusses tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma in the phase 2 Elara trial and the 5-year follow-up of a smaller CAR T-cell trial.
Latest Updated Articles
Exploring the Use of Tisagenlecleucel for Patients With LymphomaPublished: July 21st 2021 | Updated: